Robert King's Net Worth
$5.71 Million
Who is Robert King?
Robert King has an estimated net worth of $5.71 Million. This is based on reported shares across multiple companies, which include Alector, Inc., and SCICLONE PHARMACEUTICALS INC.
SEC CIK
Robert King's CIK is 0001635264
Past Insider Trading and Trends
2016 was Robert King's most active year for acquiring shares with 6 total transactions. Robert King's most active month to acquire stocks was the month of September. 2020 was Robert King's most active year for disposing of shares, totalling 7 transactions. Robert King's most active month to dispose stocks was the month of July. 2021 saw Robert King paying a total of $549,000.00 for 154,541 shares, this is the most they've acquired in one year. In 2021 Robert King cashed out on 120,250 shares for a total of $1,873,422.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alector, Inc. (ALEC) Snapshot price: $4.85
Chief Development OfficerRobert King owns 550,871 units of Common Stock which is worth $2,671,724.35. From 2019 to 2022 Robert King acquired a total of 140,482 shares in Alector, Inc. at a cost of $549,000.00, Robert also disposed a total of 120,890 shares of Alector, Inc. equalling to $3,291,684.62.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.08% | 21.58K |
—
|
—
| 550.87K |
Oct 1
| |||
Form 4
| -0.03% | -176.00 |
$10.62 | -$1,869.21 | 529.29K |
Sep 2
| |||
Form 4
| -0.03% | -177.00 |
$8.71 | -$1,541.58 | 529.47K |
Jun 2
| |||
Form 4
| -0.05% | -287.00 |
$15.57 | -$4,467.99 | 528.4K |
Mar 1
| |||
Form 4
| -0.05% | -250.00 |
$20.09 | -$5,022.50 | 528.69K |
Dec 1
| |||
Form 4/A
| +1.14% | 5.94K |
—
|
—
| 528.26K |
Oct 1
| |||
Form 4
| +1.53% | 7.97K |
—
|
—
| 530.28K |
Oct 1
| |||
Form 4
|
—
|
0
|
$20.15 | -$1,319,400.00 | 522.32K |
Scheduled
|
Jul 2
| ||
Form 4
| +9.43% | 45K |
—
|
—
| 522.32K |
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
| -3.05% | -15.00K |
$27.00 | -$404,957.58 | 477.32K |
Scheduled
|
May 15
| ||
Form 4
| -2.96% | -15.00K |
$29.56 | -$443,375.76 | 492.32K |
Scheduled
|
Feb 14
| ||
Form 4
| -2.87% | -15.00K |
$22.01 | -$330,150.00 | 507.32K |
Scheduled
|
Jan 21 - Jan 22
| ||
Form 4
| -1.42% | -7.50K |
$15.92 | -$119,400.00 | 522.32K |
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 6
| |||
Form 4
| -1.40% | -7.50K |
$15.00 | -$112,500.00 | 529.82K |
Scheduled
|
Aug 19
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SCICLONE PHARMACEUTICALS INC No price found
SVP Prod. Dev/Supply ChainRobert King owns 16,844 units of Common Stock. In the year 2015 Robert King filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$7.47 | -$295,688.63 | 16.84K |
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||